Business Wire

Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature

CAMBRIDGE, England--(BUSINESS WIRE)--Divide & Conquer (“D&C”), a biotechnology company formed in 2018 with a £10 million (approximately $13.1 million) Series A financing from Medicxi. has left stealth ...
CNN

Review: ‘Divide and Conquer’ examines Roger Ailes legacy

Roger Ailes was such a larger-than-life, swaggering figure that he practically overwhelms the attempt to distill his life into a single documentary. “Divide and Conquer: The Story of Roger Ailes” is ...